Eivind is an economist from the University of Oslo and a specialist in health economics. Eivind has many years of experience in advising on strategy and market access for the pharmaceutical industry and other health technology suppliers (including med-tech companies). With a background from various Norwegian and Nordic positions in the pharmaceutical industry and as a consultant, Eivind has extensive knowledge of the processes for access to the Nordic markets. He is also an expert in health economic analysis and modeling, assisting clients with model development, model adaptation, and quality assurance in connection with the launch of products and indications. Before joining Oslo Economics, Eivind served the market for health economic analysis and pharmaceutical economics in the Nordic region through the consultancy firm Oecona.